Drug · DIN 00830232
CONGEST
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since May 4, 2018; first marketed December 31, 1990.
- Drug Identification Number (DIN)
- 00830232
- Company (DIN owner)
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Conjugated estrogens G03CA57
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CONJUGATED ESTROGENS | 0.625 MG |
Other DINs named CONGEST
- DIN 00830208 · Dormant
- DIN 00830216 · Dormant
- DIN 00830224 · Dormant
- DIN 00830240 · Dormant